Related Experiment Video
Updated: Oct 19, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Maternal and neonatal outcomes in mothers with diabetes mellitus in qatari population
Mohammad A A Bayoumi1, Razan M Masri2, Nada Y S Matani2
1Neonatal Intensive Care Unit (NICU), Women's Wellness and Research Center (WWRC), Hamad Medical Corporation (HMC), Doha, P.O. Box 3050, Qatar. moh.abdelwahab@hotmail.com.
Insights
Maternal diabetes mellitus (DM) in Qatar is linked to increased newborn birth weight and macrosomia. Improving adherence to diabetic control programs and addressing pre-pregnancy obesity are crucial for better outcomes.
Area of Science:
- Obstetrics and Gynecology
- Neonatology
- Endocrinology
Background:
- Diabetes Mellitus (DM) significantly contributes to maternal, fetal, and neonatal complications.
- Understanding the impact of pre-pregnancy and gestational DM on newborn growth is vital for public health in Qatar.
Purpose of the Study:
- To evaluate the effects of pre-pregnancy and gestational diabetes mellitus on newborn growth parameters in the Qatari population.
- To identify risk factors associated with gestational diabetes mellitus.
Main Methods:
- A population-based cohort study comparing neonates of Qatari women with pre-pregnancy DM or gestational DM (GDM) to those of healthy non-diabetic women in 2017.
- Analysis included birth weight, length, head circumference, congenital malformations, and macrosomia rates.
- Multivariate logistic regression was used to identify risk factors for GDM.
Main Results:
- The prevalence of GDM among Qatari women in 2017 was 24.25%.
- Infants born to mothers with GDM or pre-pregnancy DM showed increased mean birth weight and a higher prevalence of macrosomia compared to controls.
- Higher maternal age, pre-pregnancy obesity, C-section delivery, and large-for-gestational-age (LGA) status were significantly associated with increased GDM risk.
Conclusions:
- Despite antenatal care, infants of diabetic mothers exhibit increased birth weight and macrosomia.
- Enhanced adherence to diabetic control programs and pre-conceptional counseling focusing on BMI are recommended.
- Pre-pregnancy obesity is a significant modifiable risk factor for gestational DM.
Background:
Diabetes Mellitus (DM) is a major cause of maternal, fetal, and neonatal morbidities. Our objective was to estimate the effect of both pre-pregnancy and gestational DM on the growth parameters of newborns in the Qatari population.
Methods:
In this population-based cohort study, we compared the data of neonates born to Qatari women with both pre-pregnancy and gestational diabetes mellitus in 2017 with neonates of healthy non-diabetic Qatari women.
Results:
Out of a total of 17020 live births in 2017, 5195 newborns were born to Qatari women. Of these, 1260 were born to women with GDM, 152 were born to women with pre-pregnancy DM and 3783 neonates were born to healthy non-diabetic (control) women. The prevalence of GDM in the Qatari population in 2017 was 24.25%. HbA1C% before delivery was significantly higher in women with pre-pregnancy DM (mean 6.19 ± 1.15) compared to those with GDM (mean 5.28 ± 0.43) (P <0.0001). The mean birth weight in grams was 3066.01 ± 603.42 in the control group compared to 3156.73 ± 577.88 in infants born to women with GDM and 3048.78 ± 677.98 in infants born to women with pre-pregnancy DM (P <0.0001). There was no statistically significant difference regarding the mean length (P= 0.080), head circumference (P= 0.514), and rate of major congenital malformations (P= 0.211). Macrosomia (Birth weight > 4000 gm) was observed in 2.7% of the control group compared to 4.8% in infants born to women with GDM, and 4.6% in infants born to women with pre-pregnancy DM (P= 0.001). Multivariate logistic regression analysis demonstrated that higher maternal age (adjusted OR 2.21, 95% CI 1.93, 2.52, P<0.0001), obesity before pregnancy (adjusted OR 1.71, 95% CI 1.30, 2.23, P<0.0001), type of delivery C-section (adjusted OR 1.25, 95% CI 1.09, 1.44, P=0.002), and body weight to gestational age LGA (adjusted OR 2.30, 95% CI 1.64, 2.34, P<0.0001) were significantly associated with increased risk of GDM.
Conclusion:
Despite the multi-disciplinary antenatal diabetic care management, there is still an increased birth weight and an increased prevalence of macrosomia among the infants of diabetic mothers. More efforts should be addressed to improve the known modifiable factors such as women's adherence to the diabetic control program. Furthermore, pre-pregnancy BMI was found to be significantly associated with gestational DM, and this is a factor that can be addressed during pre-conceptional counseling.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

